In spite of several data accumulated suggesting beneficial effects of iNOS inhibition, the enthusiasm of clinicians was reduced after a phase III study with a non-selective NOS inhibitor in human sepsis was interrupted before its conclusion [102]. Here, NOS2 is linked to Sepsis.